
Wörwag Pharma is a family-owned business with a rich history dating back to 1949. It was founded by Dr. Helmut Wörwag, a pharmacist with a passion for creating innovative products.
Wörwag Pharma is headquartered in Germany, with a strong presence in the European market. The company has a robust distribution network, ensuring timely delivery of its products to customers across the continent.
The company's product portfolio is diverse, with a focus on pharmaceuticals, dietary supplements, and cosmetics. This breadth of offerings allows Wörwag Pharma to cater to a wide range of customer needs.
A fresh viewpoint: Fabryka Samochodów Rolniczych "Polmo" W Poznaniu
Products and Operations
Wörwag Pharma offers a range of medicinal products in four categories: diabetic concomitant diseases, nervous system, immune system, and musculoskeletal system. These products are referred to as "biofactors" and include 26 biofactor brands in Germany.
Some of the notable brands in their product range are Magnerot and Milgamma, which are significant in Wörwag Pharma's portfolio.
Wörwag Pharma has two production sites: Wörwag Pharma Operations (WPO) in Lódz, Poland, and Wörwag Pharma Production (WPP) in Pöcking, Bavaria. The company guarantees a reliable supply chain through these sites, ensuring continuous access to medicines for patients.
If this caught your attention, see: Gompers V. Buck's Stove & Range Co.
Operations
Wörwag Pharma has a strong presence in various international markets. The company has expanded its operations to Eastern Europe, with branches in Hungary, Bulgaria, Poland, Slovakia, Russia, and Central Asia.
In 1996, Wörwag Pharma relocated its head office from Stuttgart to Böblingen, marking a significant milestone in its growth.
Wörwag Pharma has a global reach, with a presence in Asian and South American countries, including Vietnam and Peru. The company has also established a production facility in Poland, Wörwag Pharma Operations, which began manufacturing pharmaceuticals in May 2021.
Here are some key locations where Wörwag Pharma operates:
- Wörwag Pharma Operations (WPO) in Lódz, Poland
- Wörwag Pharma Production (WPP) in Pöcking, Bavaria, Germany
Wörwag Pharma has also acquired the Polish company Sensilab, a contract manufacturing organization, in April 2021, expanding its production capabilities.
Products
Wörwag Pharma offers a range of medicinal products that cater to various health needs. Their product range is divided into four categories: diabetic concomitant diseases, nervous system, immune system, and musculoskeletal system.
The company refers to its products as "biofactors", which are available under 26 different brand names in Germany. Two notable brands are Magnerot and Milgamma.
Explore further: Average True Range

Wörwag Pharma's product range includes medications for preventing and treating vitamin deficiencies, such as vitamin B12 and vitamin C. For example, B12 Ankermann contains cyanocobalamin to prevent and treat vitamin B12 deficiency.
Centricor Forte is another product that contains ascorbic acid to prevent and treat vitamin C deficiency. The company also offers products specifically designed to address magnesium deficiency, like Cormagnesin and magnerot CLASSIC N.
Milgamma is a product used to treat neurological system disorders, while milgamma protekt is used to treat nerve system disorders and heart-kreislauf-störungen caused by vitamin B1 deficiency.
Check this out: Avoid Prevent Burnout Work
Structure and Organization
Wörwag Pharma GmbH & Co. KG is a Kommanditgesellschaft according to German law.
Its general partner is Dr. Fritz Wörwag GmbH, a Gesellschaft mit beschränkter Haftung, which is wholly owned by the entrepreneurial family. This family also has a significant presence as limited partners, with the majority of liability contributions coming from the family-owned Wörwag GmbH and Wörwag Pharma Beteiligung GmbH.
The company's annual financial statements are consolidated with Wörwag Pharma Beteiligung GmbH, which holds equity interests in several subsidiaries.
You might enjoy: Bank Spółdzielczy W Brodnicy
Legal Form
The Wörwag Pharma GmbH & Co. KG is a Kommanditgesellschaft, a type of limited partnership according to German law.
Its general partner is the Dr. Fritz Wörwag GmbH, a Gesellschaft mit beschränkter Haftung, which is a limited liability company. This company is wholly owned by the entrepreneurial family.
The vast majority of liability contributions by the limited partners is apportioned to the family-owned Wörwag GmbH and Wörwag Pharma Beteiligung GmbH.
The annual financial statements of Wörwag Pharma GmbH & Co. KG is included in the consolidated financial statements of Wörwag Pharma Beteiligung GmbH.
This holding company has a significant stake in several subsidiaries, including FIBEG Immobilien GmbH, Generosan GmbH, and Wörwag Pharma International GmbH.
Additional reading: August Faller GmbH & Co. KG
Management
The management team at Wörwag Pharma is led by Gerhard Mayer and Jochen Schlindwein, who are both authorized signatories of the company.
Gerhard Mayer and Jochen Schlindwein are also directors of Dr. Fritz Wörwag GmbH.
Employee Count at GmbH & Co. KG

Wörwag Pharma GmbH & Co. KG has a relatively small workforce, with 520 people employed.
The employee count at Wörwag Pharma GmbH & Co. KG is 520.
For your interest: Werhof V Freeway Traffic Systems GmbH & Co KG
Auszeichnungen
Wörwag Pharma has been recognized for its achievements in various areas. The company received an IHK-Ehrenurkunde in 2021.
The Fritz Wörwag Research Award has been a significant recognition for the company's contributions to biofactors. Established in 1988, the award is endowed with 10,000 euros and recognizes research papers and well-founded reviews that make significant contributions to new experimental or clinical findings in the field of biofactors.
The award winners are selected by an independent jury. This ensures that the recognition is based on merit and not influenced by personal biases.
Here are some key facts about Wörwag Pharma's awards and recognitions:
- 2021: IHK-Ehrenurkunde
- Established the Fritz Wörwag Research Award in 1988
- Award is endowed with 10,000 euros
The Fritz Wörwag Research Award is a testament to the company's commitment to innovation and research in the field of biofactors.
CEO and Identity
Jochen Schlindwein is the CEO of Wörwag Pharma GmbH & Co. KG.
There isn't much information available about the identity of the CEO, but we do know that Jochen Schlindwein holds this position.
Wörwag Pharma GmbH & Co. KG has a clear leader in Jochen Schlindwein, who is responsible for guiding the company.
Location and Codes
Wörwag Pharma has a global presence with offices in over 35 countries, including Almaty, Baku, and Beijing.
The company's headquarters is located in Böblingen, Baden-Württemberg, and was previously based in Calwer Straße in the same city.
Wörwag Pharma also has a production facility in Konstantynów Łódzki, Poland, near the city of Łódź.
Locations
Wörwag Pharma has its headquarters in Böblingen, Baden-Württemberg. The company moved into a new company building on the Flugfeld in 2022.
The Flugfeld is an inter-municipal residential area and industrial park between Böblingen and Sindelfingen. It's a significant location for the company.
Wörwag Pharma has more than 20 country offices around the world. These offices are located in cities such as Almaty, Baku, Belgrade, and Bratislava.
These country offices manage the business in about 35 countries.
Naics Code Definition
The NAICS code is a system used by the US Census Bureau to classify businesses by industry.
NAICS stands for North American Industry Classification System.
For more insights, see: Naics Code Bank

NAICS codes are used to identify the primary and secondary activities of a business.
For example, Wörwag Pharma GmbH & Co. KG has a NAICS code of 325, which indicates that it is primarily involved in the manufacture of pharmaceuticals and medicines.
NAICS codes are six digits long and are divided into two parts: the first two digits represent the sector and the next four digits represent the industry group.
NAICS codes are used for statistical purposes, such as tracking economic trends and analyzing market data.
Businesses can have multiple NAICS codes, depending on their activities.
For instance, Wörwag Pharma GmbH & Co. KG also has NAICS codes of 32541 and 3254, indicating its involvement in the manufacture of specific types of medicines and pharmaceuticals.
NAICS codes are used by various government agencies and organizations to classify businesses and track industry trends.
See what others are reading: Nvda Digits
Featured Images: pexels.com


